Brief: Immunovia Q1 Adj. EPS at SEK -2.28
23/05/2023 07:31
May 23 (Reuters) - Immunovia Q1 adjusted EPS SEK -2.28. * Q1 net income SEK -51.7 million * Q1 adjusted free cash flow SEK -39.7 million * Q1 revenue SEK 520 thousand
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study